Tandem Investment Advisors Inc. grew its holdings in Genpact Limited (NYSE:G – Free Report) by 6.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,270,143 shares of the business services provider’s stock after purchasing an additional 140,228 shares during the quarter. Genpact comprises about 4.0% of Tandem Investment Advisors Inc.’s portfolio, making the stock its 6th biggest position. Tandem Investment Advisors Inc. owned approximately 1.29% of Genpact worth $114,370,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Coppell Advisory Solutions LLC lifted its stake in shares of Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider’s stock valued at $25,000 after purchasing an additional 503 shares during the period. Atlas Capital Advisors Inc. raised its stake in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock worth $26,000 after buying an additional 216 shares during the period. GeoWealth Management LLC raised its stake in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider’s stock worth $38,000 after buying an additional 583 shares during the period. Smartleaf Asset Management LLC raised its stake in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after buying an additional 783 shares during the period. Finally, Global X Japan Co. Ltd. acquired a new position in Genpact during the 1st quarter worth approximately $57,000. 96.03% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on the company. Robert W. Baird dropped their price target on Genpact from $56.00 to $50.00 and set a “neutral” rating on the stock in a research note on Thursday, May 8th. Wall Street Zen raised Genpact from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 6th. Mizuho increased their price objective on Genpact from $48.00 to $51.00 and gave the stock a “neutral” rating in a research note on Tuesday. Finally, Needham & Company LLC reissued a “buy” rating and issued a $50.00 price objective on shares of Genpact in a research note on Monday. Four research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $50.14.
Insiders Place Their Bets
In related news, Director Nicholas C. Gangestad bought 2,000 shares of the company’s stock in a transaction on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director directly owned 2,000 shares in the company, valued at approximately $87,940. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 3.07% of the company’s stock.
Genpact Stock Performance
G stock opened at $44.99 on Thursday. The firm has a market cap of $7.87 billion, a PE ratio of 15.35, a P/E/G ratio of 1.96 and a beta of 0.94. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.48. The business has a 50 day moving average of $44.39 and a 200-day moving average of $46.89. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76.
Genpact (NYSE:G – Get Free Report) last released its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. Genpact’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the company posted $0.73 earnings per share. As a group, sell-side analysts expect that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th were issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend was Wednesday, June 18th. Genpact’s dividend payout ratio (DPR) is 23.21%.
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback
- What is a Low P/E Ratio and What Does it Tell Investors?
- Nike’s Stock Just Got an Upgrade: Is a Real Comeback Brewing?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Rocket Lab: Latest Catalysts Bolster the Bull Case
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.